Related Experiment Video
Updated: Jun 4, 2026
09:37
Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold
Published on: October 23, 2015
Development of an osteoconductive PCL-PDIPF-hydroxyapatite composite scaffold for bone tissue engineering
Juan Manuel Fernandez1, M Silvina Molinuevo, M Susana Cortizo
1Grupo de Investigación en Osteopatías y Metabolismo Mineral, Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, 1900 La Plata, Argentina.
Journal of Tissue Engineering and Regenerative Medicine
|February 12, 2011
Summary
A novel hydroxyapatite (HAP)-containing composite shows improved mechanical and biocompatibility properties for bone tissue engineering. This HAP-Blend material enhances osteogenic cell activity, offering a promising alternative for bone regeneration applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Nanotechnology
Background:
- Bone tissue engineering requires advanced materials with suitable mechanical properties and biocompatibility.
- Polymeric composites incorporating hydroxyapatite (HAP) are explored for bone regeneration.
- Poly-ε-caprolactone (PCL) and polydiisopropyl fumarate (PDIPF) blends offer tunable properties for biomedical applications.
Purpose of the Study:
- To develop and evaluate a novel hydroxyapatite (HAP)-containing poly-ε-caprolactone (PCL)-polydiisopropyl fumarate (PDIPF) composite (Blend) for bone tissue engineering.
- To assess the physicochemical, mechanical, and biocompatibility properties of the HAP-Blend composite.
- To compare the performance of the HAP-Blend composite with a blend lacking HAP and PCL/HAP films.
Main Methods:
- Fabrication of HAP-containing PCL-PDIPF composite (Blend-HAP).
- Evaluation of physicochemical and mechanical properties (elastic modulus, elongation-at-break).
- In vitro assessment of biocompatibility and osteogenicity using osteoblast-like cell lines (UMR106, MC3T3E1).
Main Results:
- The HAP-Blend composite exhibited enhanced mechanical properties, indicated by increased elastic modulus and decreased elongation-at-break.
- Addition of HAP significantly improved cell biocompatibility and osteogenicity.
- HAP incorporation led to increased osteoblastic cell proliferation, alkaline phosphatase (ALP) expression, type-I collagen production, and Runx-2 levels.
Conclusions:
- A novel, biocompatible HAP-Blend composite with uniformly dispersed HAP nanoparticles and good interphase compatibility was successfully prepared.
- The developed HAP-Blend composite demonstrates improved physical, mechanical, and osteoinductive properties.
- This HAP-Blend composite holds significant potential for applications in bone tissue engineering.
